UOC
UBS O'Connor Portfolio holdings
AUM
$1.93B
1-Year Return
38.75%
This Quarter Return
+15.38%
1 Year Return
+38.75%
3 Year Return
+182.42%
5 Year Return
+480.25%
10 Year Return
+1,573.29%
AUM
$3.3B
AUM Growth
-$463M
(-12%)
Cap. Flow
-$632M
Cap. Flow
% of AUM
-19.12%
Top 10 Holdings %
Top 10 Hldgs %
73.53%
Holding
460
New
59
Increased
65
Reduced
85
Closed
138
Top Buys
| 1 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
$405M |
| 2 |
DFS
Discover Financial Services
DFS
|
$209M |
| 3 |
BECN
Beacon Roofing Supply, Inc.
BECN
|
$195M |
| 4 |
HEES
H&E Equipment Services
HEES
|
$103M |
| 5 |
JWN
Nordstrom
JWN
|
$96.6M |
Top Sells
| 1 |
Kellanova
K
|
$305M |
| 2 |
HCP
HashiCorp, Inc. Class A Common Stock
HCP
|
$235M |
| 3 |
SMAR
Smartsheet Inc.
SMAR
|
$216M |
| 4 |
EDR
Endeavor Group Holdings, Inc.
EDR
|
$144M |
| 5 |
SUM
Summit Materials, Inc. Class A Common Stock
SUM
|
$103M |
Sector Composition
| 1 | Energy | 21.95% |
| 2 | Financials | 16.66% |
| 3 | Healthcare | 15.59% |
| 4 | Technology | 13.54% |
| 5 | Industrials | 12.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CLBR
126
DELISTED
Colombier Acquisition Corp II
CLBR
| $1.6M | 0.05% |
150,000
-41,738
| -22% | -$445K |
|
127
Teva Pharmaceuticals
TEVA
$21.7B
| $1.55M | 0.05% |
100,788
-37,237
| -27% | -$572K |
|
128
Credicorp
BAP
$20.7B
| $1.55M | 0.05% |
8,311
| – | – |
|
|
POLE
129
Andretti Acquisition Corp. II Class A Ordinary Shares
POLE
$307M
| $1.52M | 0.05% |
150,000
| – | – |
|
130
Rezolute
RZLT
$696M
| $1.46M | 0.04% |
502,908
-23,315
| -4% | -$67.6K |
|
131
Orthofix Medical
OFIX
$575M
| $1.45M | 0.04% |
89,059
-8,402
| -9% | -$137K |
|
132
Viridian Therapeutics
VRDN
$1.53B
| $1.44M | 0.04% |
107,088
+62,488
| +140% | +$842K |
|
133
Align Technology
ALGN
$10.1B
| $1.44M | 0.04% |
9,050
+1,800
| +25% | +$286K |
|
134
iRhythm Technologies
IRTC
$5.82B
| $1.41M | 0.04% |
13,506
-5,685
| -30% | -$595K |
|
135
Genmab
GMAB
$16.9B
| $1.41M | 0.04% |
+71,877
| New | +$1.41M |
|
136
Adaptive Biotechnologies
ADPT
$1.96B
| $1.4M | 0.04% |
187,789
-26,040
| -12% | -$193K |
|
|
AACT
137
Ares Acquisition Corporation II
AACT
$706M
| $1.39M | 0.04% |
125,000
-40,422
| -24% | -$451K |
|
138
Crinetics Pharmaceuticals
CRNX
$3.35B
| $1.36M | 0.04% |
40,613
+12,926
| +47% | +$434K |
|
|
PVLA
139
Palvella Therapeutics, Inc. Common Stock
PVLA
$616M
| $1.36M | 0.04% |
+48,664
| New | +$1.36M |
|
140
Evolv Technologies
EVLV
$1.39B
| $1.34M | 0.04% |
430,223
| – | – |
|
141
Immunocore
IMCR
$1.87B
| $1.34M | 0.04% |
45,196
-78
| -0.2% | -$2.31K |
|
142
Dollar General
DG
$24.1B
| $1.32M | 0.04% |
+15,000
| New | +$1.32M |
|
|
BPMC
143
DELISTED
Blueprint Medicines
BPMC
| $1.32M | 0.04% |
14,865
-5,268
| -26% | -$466K |
|
144
Inspire Medical Systems
INSP
$2.56B
| $1.27M | 0.04% |
+8,000
| New | +$1.27M |
|
|
BCYC
145
Bicycle Therapeutics
BCYC
$496M
| $1.26M | 0.04% |
148,722
+68,486
| +85% | +$581K |
|
146
Treace Medical Concepts
TMCI
$453M
| $1.24M | 0.04% |
147,695
-126,505
| -46% | -$1.06M |
|
147
uniQure
QURE
$985M
| $1.22M | 0.04% |
114,889
-77,334
| -40% | -$820K |
|
148
Soleno Therapeutics
SLNO
$3.71B
| $1.22M | 0.04% |
17,022
+9,045
| +113% | +$646K |
|
149
Ingersoll Rand
IR
$32.2B
| $1.2M | 0.04% |
+15,000
| New | +$1.2M |
|
150
PTC Therapeutics
PTCT
$4.55B
| $1.19M | 0.04% |
23,353
-23,541
| -50% | -$1.2M |
|